74 related articles for article (PubMed ID: 24726492)
1. Multiplex detection of KRAS mutations by a matrix-assisted laser desorption/ionization-time of flight mass spectrometry assay.
Choi HS; Min KT; Cha YS; Hong SP
Clin Biochem; 2014 Aug; 47(12):1091-7. PubMed ID: 24726492
[TBL] [Abstract][Full Text] [Related]
2. Results of first proficiency test for KRAS testing with formalin-fixed, paraffin-embedded cell lines in China.
Zhang R; Han Y; Huang J; Ma L; Li Y; Li J
Clin Chem Lab Med; 2014 Dec; 52(12):1851-7. PubMed ID: 24945428
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization.
Kim HS; Han KH; Ahn SH; Kim EO; Chang HY; Moon MS; Chung HJ; Yoo W; Kim SO; Hong SP
Antivir Ther; 2005; 10(3):441-9. PubMed ID: 15918335
[TBL] [Abstract][Full Text] [Related]
4. Comparison of mass spectrometric analysis and TRUGENE HBV genotyping for monitoring lamivudine resistance in chronic hepatitis B patients.
Woo HY; Park H; Kim BI; Jeon WK; Cho YK; Kim YJ
Antivir Ther; 2007; 12(1):7-13. PubMed ID: 17503742
[TBL] [Abstract][Full Text] [Related]
5. Validation of a Multiplex Allele-Specific Polymerase Chain Reaction Assay for Detection of KRAS Gene Mutations in Formalin-Fixed, Paraffin-Embedded Tissues from Colorectal Cancer Patients.
Seekhuntod S; Thavarungkul P; Chaichanawongsaroj N
PLoS One; 2016; 11(1):e0147672. PubMed ID: 26812617
[TBL] [Abstract][Full Text] [Related]
6. Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B.
Han KH; Hong SP; Choi SH; Shin SK; Cho SW; Ahn SH; Hahn JS; Kim SO
Antivir Ther; 2011; 16(1):77-87. PubMed ID: 21311111
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
[TBL] [Abstract][Full Text] [Related]
8. High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS , BRAF , PIK3CA , and AKT1 mutations in formalin-fixed, paraffin-embedded tissues.
Ney JT; Froehner S; Roesler A; Buettner R; Merkelbach-Bruse S
Arch Pathol Lab Med; 2012 Sep; 136(9):983-92. PubMed ID: 22938585
[TBL] [Abstract][Full Text] [Related]
9. Pyrosequencing method to detect KRAS mutation in formalin-fixed and paraffin-embedded tumor tissues.
Dufort S; Richard MJ; de Fraipont F
Anal Biochem; 2009 Aug; 391(2):166-8. PubMed ID: 19464247
[TBL] [Abstract][Full Text] [Related]
10. Optimized Multiplex Detection of 7 KRAS Mutations by Taqman Allele-Specific qPCR.
Orue A; Rieber M
PLoS One; 2016; 11(9):e0163070. PubMed ID: 27632281
[TBL] [Abstract][Full Text] [Related]
11. Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients.
Taly V; Pekin D; Benhaim L; Kotsopoulos SK; Le Corre D; Li X; Atochin I; Link DR; Griffiths AD; Pallier K; Blons H; Bouché O; Landi B; Hutchison JB; Laurent-Puig P
Clin Chem; 2013 Dec; 59(12):1722-31. PubMed ID: 23938455
[TBL] [Abstract][Full Text] [Related]
12. Detection of KRAS mutations in colorectal cancer by high-resolution melting analysis.
Ma ES; Wong CL; Law FB; Chan WK; Siu D
J Clin Pathol; 2009 Oct; 62(10):886-91. PubMed ID: 19783717
[TBL] [Abstract][Full Text] [Related]
13. Absence of evidence for epidermal growth factor receptor and human homolog of the Kirsten rat sarcoma-2 virus oncogene mutations in breast cancer.
Lv N; Lin S; Xie Z; Tang J; Ge Q; Wu M; Xie X; Xie X; Wei W
Cancer Epidemiol; 2012 Aug; 36(4):341-6. PubMed ID: 22386733
[TBL] [Abstract][Full Text] [Related]
14. A novel mutant-enriched liquidchip technology for the qualitative detection of somatic mutations in KRAS gene from both serum and tissue samples.
Wu S; Zhu Z; He J; Luo X; Xu J; Ren-Heidenreich L
Clin Chem Lab Med; 2010 Aug; 48(8):1103-6. PubMed ID: 20482381
[TBL] [Abstract][Full Text] [Related]
15. Polymerase chain reaction/sequencing analysis of ras mutations in paraffin-embedded tissues as compared with 3T3 transfection and polymerase chain reaction/sequencing of frozen tumor deoxyribonucleic acids.
Goodrow TL; Prahalada SR; Storer RD; Manam SV; Leander KR; Kraynak AR; van Zwieten MJ; Nichols WW; Bradley MO
Lab Invest; 1992 Apr; 66(4):504-11. PubMed ID: 1583889
[TBL] [Abstract][Full Text] [Related]
16. Targeted data-independent acquisition for mass spectrometric detection of RAS mutations in formalin-fixed, paraffin-embedded tumor biopsies.
Kim YJ; Chambers AG; Cecchi F; Hembrough T
J Proteomics; 2018 Oct; 189():91-96. PubMed ID: 29684684
[TBL] [Abstract][Full Text] [Related]
17. Detection of N-, H-, and KRAS codons 12, 13, and 61 mutations with universal RAS primer multiplex PCR and N-, H-, and KRAS-specific primer extension.
Chang YS; Yeh KT; Hsu NC; Lin SH; Chang TJ; Chang JG
Clin Biochem; 2010 Feb; 43(3):296-301. PubMed ID: 19879255
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive procedural approach to genotyping KRAS and BRAF from paraffin embedded tissues for diagnostic purposes.
Palmirotta R; Ludovici G; De Marchis ML; Leone B; Formica V; Ettorre GM; Cavaliere F; Della-Morte D; Ferroni P; Roselli M; Guadagni F
In Vivo; 2012; 26(4):537-47. PubMed ID: 22773565
[TBL] [Abstract][Full Text] [Related]
19. EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.
Schmid K; Oehl N; Wrba F; Pirker R; Pirker C; Filipits M
Clin Cancer Res; 2009 Jul; 15(14):4554-60. PubMed ID: 19584155
[TBL] [Abstract][Full Text] [Related]
20. KRAS mutation status in primary nonsmall cell lung cancer and matched metastases.
Cortot AB; Italiano A; Burel-Vandenbos F; Martel-Planche G; Hainaut P
Cancer; 2010 Jun; 116(11):2682-7. PubMed ID: 20336783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
